Aarti Drugs Limited, through its subsidiaries, engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
Aarti Drugs Limited (AARTIDRUGS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AARTIDRUGS share price is ₹449.90 (+0.98% today), with a market capitalisation of ₹41B and a price-to-earnings (P/E) ratio of 21.5. MarketRipple tracks the AARTIDRUGS investment thesis, the ripple-chain impact of market events on Aarti Drugs Limited, and the Healthcare sector outlook.
Open
₹454.65
High
₹455.00
Low
₹447.55
Prev. Close
₹445.55
52W High
₹534.00
52W Low
₹318.95
Day range
₹447.55–₹455.00
52-week range
₹318.95–₹534.00
Volume
129K
P/E
21.5
ROE
14.5%
D/E
0.37
Margin
8.0%
Aarti Drugs Limited (NSE: AARTIDRUGS) is currently trading at ₹449.90 (+0.98%).
Aarti Drugs Limited's market capitalization is ₹41B.
Aarti Drugs Limited's price-to-earnings (P/E) ratio is 21.5.
Aarti Drugs Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Aarti Drugs Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.